DarioHealth cites Aon review estimating 2.5%-7.2% annual reduction in total healthcare costs

• DarioHealth announced results from an independent Aon review released Oct. 6, 2026; findings have already been presented.
• The analysis supported an in-year reduction in total healthcare costs across a covered population, not limited to program participants.
• A separate study review indicated the platform was linked to fewer hospitalizations for users with type 2 diabetes versus matched non-users.
• For a 20,000-life population, Aon estimated annual savings of $3.8 million to $10.8 million, depending on disease burden.
• Aon also estimated additional savings potential from multi-condition management with direct physician access, lifting total savings potential to 10% annually.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DarioHealth Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610060730PR_NEWS_USPR_____LN63040) on October 06, 2026, and is solely responsible for the information contained therein.